Form 4: Sight Sciences COO Sells Shares for Tax Cover
Insider Transaction Filing
Sight Sciences' Chief Operating Officer, Alison Bauerlein, sold 25,874 shares of common stock to cover tax liabilities related to vesting restricted stock units.
Summary
- Alison Bauerlein, Chief Operating Officer of Sight Sciences, Inc., reported a transaction on April 2, 2026.
- The transaction involved the sale of 25,874 shares of common stock.
- These shares were sold to cover the reporting person's tax liability arising from the vesting of restricted stock units (RSUs).
- The weighted average sale price was $3.48 per share, with individual sales ranging from $3.43 to $3.59.
- Following this transaction, Bauerlein beneficially owns 701,621 shares of common stock.
- This ownership includes 156,788 directly held shares and 544,833 shares to be acquired upon the vesting and settlement of unvested RSUs.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sale is a standard procedure for covering tax obligations related to equity compensation and does not necessarily reflect a negative view of the company's performance.
Positives
- The sale was conducted to cover tax liabilities, a common and expected event for executives receiving equity compensation.
- The reporting person retains a significant beneficial ownership of 701,621 shares, indicating continued commitment to the company.
Negatives
- A portion of the executive's equity compensation was sold, reducing their direct holdings.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing, which solely reports a past transaction.
Industry Context
StockSavvy.ai notes that insider sales for tax cover are routine events for executives in the biotechnology and medical device sectors, particularly following RSU vesting. The key for investors is to distinguish these planned transactions from sales driven by a lack of confidence in the company's future prospects.
Stakeholder Impact
- Shareholders: The sale is a routine event and unlikely to have a significant impact on the share price, as it was for tax cover. The continued substantial beneficial ownership by the COO suggests ongoing alignment with shareholder interests.
Key Dates
| Date | Description |
|---|---|
| 04/02/2026 | Transaction Date for sale of common stock. |
| 04/03/2026 | Date of signature for the filing. |
Keywords
Form 4, Insider Transaction, Stock Sale, Tax Cover, Restricted Stock Units, Vesting, Beneficial Ownership, Sight Sciences, SGHT, Alison Bauerlein, Chief Operating Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.